Patent ID: 11919900
Assignee: KING FAISAL UNIVERSITY
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The method of claim 1, wherein the compound is selected from the group consisting of:
Dimethyl 4-bromo-1-(4-methoxybenzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylate (QUIN-KNV1);
Ethyl 4-bromo-1-(4-methoxybenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (QUIN-KNV2);
Dimethyl 4-bromo-1-(4-chlorobenzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylate (QUIN-KNV3);
Ethyl 4-bromo-1-(4-chlorobenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (QUIN-KNV4);
Dimethyl 4-bromo-1-(4-bromobenzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylate (QUIN-KNV5);
Ethyl 4-bromo-1-(4-bromobenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (QUIN-KNV6);
Dimethyl 4-bromo-1-(4-fluorobenzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylate (QUIN-KNV7);
Ethyl 4-bromo-1-(4-fluorobenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (QUIN-KNV8);
Dimethyl 4-bromo-1-(4-cyanobenzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylate (QUIN-KNV9);
Ethyl 4-bromo-1-(4-cyanobenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (QUIN-KNV10);
Dimethyl 1-benzoyl-4-bromopyrrolo[1,2-a]quinoline-2,3-dicarboxylate (QUIN-KNV11);
Ethyl 4-bromo-1-(2-nitrobenzoyl)pyrrolo[1,2-a]quinoline-3-carboxylate (QUIN-KNV12);
and a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof.